SEC Form 4
Hims & Hers Health, Inc. (HIMS) insider trading
In the 12 months to Oct 24, 2026, 8 HIMS insiders reported open-market sales of $19.4M across 43 filings; one director bought $1.2M.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $19.4M
- 43 filings · 8 insiders
- Open-market purchases
- $1.2M
- 1 filing · David B. Wells, Director
- Pre-arranged sales (10b5-1)
- 42 of 43
- $19.3M of $19.4M sold (99%)
Who traded HIMS, and when
- Purchase
- Sale
- Sale, pre-arranged (10b5-1)
HIMS daily close from Oct 24, 2025 to Oct 23, 2026, between $14.52 and $48.78, last $27.71. 43 sale and 1 purchase filings by 9 insiders, marked at their filing dates. Oluyemi Okupe, Chief Financial Officer: sold $9.7M across 18 filings, first filed Nov 19, 2025, last Oct 2, 2026. Michael Chi, Chief Operating Officer: sold $3.7M across 4 filings, first filed Dec 18, 2025, last Sep 17, 2026. Soleil Boughton, Chief Legal Officer: sold $2.0M across 11 filings, first filed Oct 28, 2025, last Oct 15, 2026. Patrick Harrison Carroll, Chief Medical Officer: sold $1.2M across 2 filings, first filed Dec 18, 2025, last Jun 23, 2026. David B. Wells, Director: bought $1.2M across 1 filing, first filed May 26, 2026, last May 26, 2026. Mohamed Elshenawy, CTO: sold $1.2M across 2 filings, first filed Jun 17, 2026, last Sep 17, 2026. 3 others: sold $1.6M across 6 filings, first filed Dec 10, 2025, last Aug 20, 2026.
Largest mark · tap a row for others
Michael Chi · Chief Operating Officer
Sale $2,402,065
97,289 shares at $24.69 avg
Filed Mar 18, 2026 · traded Mar 17
Pre-arranged (10b5-1) · close on filing date $23.15
Oluyemi Okupe · Chief Financial Officer
Chief Financial Officer
$9.7M soldMichael Chi · Chief Operating Officer
Chief Operating Officer
$3.7M soldSoleil Boughton · Chief Legal Officer
Chief Legal Officer
$2.0M soldPatrick Harrison Carroll · Chief Medical Officer
Chief Medical Officer
$1.2M soldDavid B. Wells · Director
Director
$1.2M boughtMohamed Elshenawy · CTO
CTO
$1.2M sold3 others
Combined, one mark per week
$1.6M soldHas Hims & Hers Health, Inc.'s CEO sold stock?
No. Andrew Dudum (CEO) made no open-market sales filed as CEO in the last 12 months.
Open-market trades
44 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Oluyemi Okupe | Chief Financial Officer | $9.7M | — | 18 | 100% of sales | |
| Michael Chi | Chief Operating Officer | $3.7M | — | 4 | 100% of sales | |
| Soleil Boughton | Chief Legal Officer | $2.0M | — | 11 | 100% of sales | |
| Patrick Harrison Carroll | Chief Medical Officer | $1.2M | — | 2 | 100% of sales | |
| David B. Wells | Director | — | $1.2M | 1 | — | |
| Mohamed Elshenawy | CTO | $1.2M | — | 2 | 100% of sales | |
| Irene Becklund | PAO | $815.8K | — | 3 | 100% of sales | |
| Deborah M. Autor | Chief Policy Officer | $726.1K | — | 2 | 100% of sales | |
| Garcia Andrea G. Perez | Director | $97.9K | — | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Soleil Boughton Chief Legal Officer | SalePre-arranged (10b5-1) | 3,461 | $29.06 | $100.6K | 297,348 | |
traded | Soleil Boughton Chief Legal Officer | SalePre-arranged (10b5-1) | 3,461 | $29.17 | $101.0K | 300,809 | |
traded | Oluyemi Okupe Chief Financial Officer | SalePre-arranged (10b5-1) | 2,000 | $29.70 | $59.4K | 234,527 | |
traded | Oluyemi Okupe Chief Financial Officer | SalePre-arranged (10b5-1) | 29,277 | $29.95 | $876.8K | 236,527 | |
traded | Oluyemi Okupe Chief Financial Officer | SalePre-arranged (10b5-1) | 12,313 | $28.82 | $354.9K | 251,804 | |
traded | Soleil Boughton Chief Legal Officer | SalePre-arranged (10b5-1) | 6,236 | $27.86 | $173.7K | 304,270 | |
traded | Michael Chi Chief Operating Officer | SalePre-arranged (10b5-1) | 14,027 | $28.39 | $398.2K | 456,660 | |
traded | Mohamed Elshenawy CTO | SalePre-arranged (10b5-1) | 7,954 | $28.39 | $225.8K | 185,556 | |
traded | Soleil Boughton Chief Legal Officer | SalePre-arranged (10b5-1) | 3,458 | $28.33 | $98.0K | 310,506 | |
traded | Soleil Boughton Chief Legal Officer | SalePre-arranged (10b5-1) | 25,111 | $27.55 | $691.8K | 313,964 | |
traded | Deborah M. Autor Chief Policy Officer | SalePre-arranged (10b5-1) | 16,773 | $27.85 | $467.1K | 48,961 | |
traded | Oluyemi Okupe Chief Financial Officer | SalePre-arranged (10b5-1) | 4,938 | $29.99 | $148.1K | 264,117 | |
traded | Oluyemi Okupe Chief Financial Officer | SalePre-arranged (10b5-1) | 64,771 | $34.05 | $2.2M | 264,117 | |
traded | Oluyemi Okupe Chief Financial Officer | SalePre-arranged (10b5-1) | 7,163 | $31.99 | $229.2K | 284,321 | |
traded | Oluyemi Okupe Chief Financial Officer | SalePre-arranged (10b5-1) | 7,163 | $36.49 | $261.4K | 284,321 | |
traded | Oluyemi Okupe Chief Financial Officer | SalePre-arranged (10b5-1) | 18,197 | $34.03 | $619.2K | 284,321 | |
traded | Patrick Harrison Carroll Chief Medical Officer | SalePre-arranged (10b5-1) | 23,726 | $35.00 | $830.4K | 181,861 | |
traded | Mohamed Elshenawy CTO | SalePre-arranged (10b5-1) | 30,040 | $31.50 | $946.3K | 101,023 | |
traded | Irene Becklund PAO | SalePre-arranged (10b5-1) | 12,063 | $30.72 | $370.5K | 6,790 | |
traded | Michael Chi Chief Operating Officer | SalePre-arranged (10b5-1) | 14,027 | $31.50 | $441.9K | 432,124 | |
traded | David B. Wells Director | Purchase | 48,400 | $24.24 | $1.2M | 224,417 | |
traded | Oluyemi Okupe Chief Financial Officer | SalePre-arranged (10b5-1) | 7,950 | $23.64 | $187.9K | 262,954 | |
traded | Soleil Boughton Chief Legal Officer | SalePre-arranged (10b5-1) | 9,463 | $30.00 | $283.9K | 299,368 | |
traded | Oluyemi Okupe Chief Financial Officer | SalePre-arranged (10b5-1) | 19,645 | $29.96 | $588.6K | 262,954 | |
traded | Oluyemi Okupe Chief Financial Officer | SalePre-arranged (10b5-1) | 54,927 | $26.53 | $1.5M | 270,046 | |
traded | Oluyemi Okupe Chief Financial Officer | SalePre-arranged (10b5-1) | 3,975 | $19.98 | $79.4K | 318,789 | |
traded | Oluyemi Okupe Chief Financial Officer | SalePre-arranged (10b5-1) | 9,217 | $23.77 | $219.1K | 318,789 | |
traded | Soleil Boughton Chief Legal Officer | SalePre-arranged (10b5-1) | 4,812 | $24.69 | $118.8K | 308,831 | |
traded | Irene Becklund PAO | SalePre-arranged (10b5-1) | 5,529 | $24.69 | $136.5K | 8,752 | |
traded | Michael Chi Chief Operating Officer | SalePre-arranged (10b5-1) | 97,289 | $24.69 | $2.4M | 407,282 | |
traded | Soleil Boughton Chief Legal Officer | SalePre-arranged (10b5-1) | 4,651 | $15.21 | $70.7K | 440,972 | |
traded | Oluyemi Okupe Chief Financial Officer | SalePre-arranged (10b5-1) | 5,262 | $26.44 | $139.1K | 91,617 | |
traded | Oluyemi Okupe Chief Financial Officer | SalePre-arranged (10b5-1) | 9,067 | $30.34 | $275.1K | 91,617 | |
traded | Oluyemi Okupe Chief Financial Officer | SalePre-arranged (10b5-1) | 9,070 | $33.79 | $306.5K | 91,617 | |
traded | Oluyemi Okupe Chief Financial Officer | SalePre-arranged (10b5-1) | 23,090 | $35.72 | $824.7K | 94,333 | |
traded | Patrick Harrison Carroll Chief Medical Officer | SalePre-arranged (10b5-1) | 10,021 | $36.71 | $367.9K | 169,940 | |
traded | Deborah M. Autor Chief Policy Officer | SalePre-arranged (10b5-1) | 7,054 | $36.71 | $259.0K | 6,175 | |
traded | Irene Becklund PAO | SalePre-arranged (10b5-1) | 8,411 | $36.71 | $308.8K | 2,126 | |
traded | Michael Chi Chief Operating Officer | SalePre-arranged (10b5-1) | 13,750 | $36.71 | $504.8K | 305,161 | |
traded | Garcia Andrea G. Perez Director | Sale | 2,500 | $39.17 | $97.9K | 80,166 | |
traded | Soleil Boughton Chief Legal Officer | SalePre-arranged (10b5-1) | 2,631 | $35.22 | $92.7K | 153,225 | |
traded | Oluyemi Okupe Chief Financial Officer | SalePre-arranged (10b5-1) | 23,187 | $36.81 | $853.5K | 70,232 | |
traded | Soleil Boughton Chief Legal Officer | SalePre-arranged (10b5-1) | 2,637 | $42.53 | $112.2K | 155,856 | |
traded | Soleil Boughton Chief Legal Officer | SalePre-arranged (10b5-1) | 2,637 | $50.10 | $132.1K | 158,493 |
GET /stocks/filings/vX/form-4?tickers=HIMS&filing_date.gte=2025-10-24&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"HIMS"
],
"issuer_cik": "0001773751",
"owner_cik": "0001837817",
"accession_number": "0001773751-26-000227",
"form_type": "4",
"filing_date": "2026-10-15",
"period_of_report": "2026-10-14",
"issuer_name": "Hims & Hers Health, Inc.",
"issuer_trading_symbol": "HIMS",
"owner_name": "Boughton Soleil",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "Chief Legal Officer",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Class A Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": true,
"transaction_date": "2026-10-14",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 3461,
"transaction_price_per_share": 29.06,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 297348,
"transaction_value": 100576.65999999999,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2026 by the Reporting Person."
}
]
},
{
"tickers": [
"HIMS"
],
"issuer_cik": "0001773751",
"owner_cik": "0001837817",
"accession_number": "0001837817-26-000017",
"form_type": "4",
"filing_date": "2026-10-02",
"period_of_report": "2026-09-30",
"issuer_name": "Hims & Hers Health, Inc.",
"issuer_trading_symbol": "HIMS",
"owner_name": "Boughton Soleil",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "Chief Legal Officer",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Class A Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": true,
"transaction_date": "2026-09-30",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 3461,
"transaction_price_per_share": 29.17,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 300809,
"transaction_value": 100957.37000000001,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2026 by the Reporting Person."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 119 records
- Option exercises68 records
- Tax withholding33 records
- Grants and awards4 records
- Gifts12 records
- Other2 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
Build this yourself
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for HIMS every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Pre-arranged (10b5-1)
- The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.